Clinical Trial Update: Efficacy of Spectrally Optimized Light on Cognitive Impairment in Major Depressive Disorder and Its Neuroimaging Mechanisms [NA]

View source ↗

Summary

This ClinicalTrials.gov entry describes a study evaluating whether spectrally optimized light can improve cognitive impairment in major depressive disorder and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Peking University Sixth Hospital | Conditions: Major Depressive Disorder (MDD), Neuroimaging | NA | Status: NOT_YET_RECRUITING